Noa Therapeutics Receives the Women Entrepreneur Grant at CanWIN 2024

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Noa Therapeutics, a preclinical Canadian biotech company aiming to defy the convention of traditional drug development to revolutionize treatment options for those living with complex inflammatory skin diseases, has received the Women Entrepreneur $5,000 grant at the CanWIN 2024 Bridge to Asia Pitch competition.

Noa Therapeutics is an OBIO® member, alumnus of our BDSP™, H2BB™ and WiHI programs, and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Roga Secures $1.7 Million CAD to Reduce Stress and Burnout with its Nerve-Stimulating Website
Next

Revolutionizing Stroke Treatment: The Ottawa Hospital First To Adopt Vena Medical’s Innovative Device